Tag: ROS1

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to ROS1

Landscape of somatic alterations in large-scale solid tumors from an Asian population

Added to Collection on: 2022-07-23 15:36:24

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
UBR-1 on ROS2 Humble - Robohub

Added to Collection on: 2022-08-04 11:14:49

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Nerviano Medical Sciences S.r.l. Announces Collaboration and Option to License ...

Added to Collection on: 2022-09-21 11:22:08

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Biotech Co. Achieves High ORRs in Ph. 1 NSCLC Trial - Streetwise Reports

Added to Collection on: 2022-10-28 20:51:56

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Week in Review: Mitigating testing bottlenecks | new CRISPR enzyme | FDA liquid biopsy approval

Added to Collection on: 2023-01-06 09:01:29

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Updates: MET targeted therapy for EXON 14 mutations in lung cancer - EurekAlert!

Added to Collection on: 2023-09-12 13:58:34

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Dosing webpage lands Roche in U.K. pharma marketing watchdog's crosshairs

Added to Collection on: 2023-09-21 20:10:19

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals ... - PipelineReview.com

Added to Collection on: 2024-01-09 15:15:16

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
RUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancer

Added to Collection on: 2025-02-06 17:22:11

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Strategic and Safe Lorlatinib Use Is Key to Optimal ALK+ NSCLC Management - OncLive

Added to Collection on: 2025-02-21 21:19:48

Tags for this article:

Click the tags to see associated articles and topics

View Article Details